This is the authors' abstract. We don't add key points for this paper.
Choose what is best; custom will make it agreeable. Pythagoras Clinical decision making in determining the surgical management of intrinsic hyperopia is dependent on many factors. The surgical options are refractive lens exchange (RLE), phakic intraocular lens (pIOL) implantation, and laser vision correction (LVC). Thermal keratoplasty is now relegated to history since its permanence has not been proven despite different methodologies. Similarly, corneal inlays have not achieved recognition except as an experimental option. Hyperopia is due to a short axial length, an unusually flat cornea, or a combination of these. It is classified as low up to +2.00 diopters (D), which is a manageable burden for the young until premature presbyopia sets in, moderate from +2.00 to +4.00 D, and high beyond that range. At the highest end of the range, when (aphakia apart) axial lengths are very short, nanophthalmos brings other issues into consideration. The most contentious area of surgical management concerns the application of LVC. What is the reasonable range of hyperopia to which LVC is applicable? In this issue, Desai et al. (pages 232–237) present a long-term follow-up of hyperopic laser in situ keratomileusis (LASIK) correction using the Visx Star S2 excimer laser. They conclude that LVC was safe, effective, and predictable for hyperopia up to +4.10 D (the mean in the high-hyperopia group). A mild regression of refractive effect was seen over the 5-year period. However, in a study using the Technolas 117 platform, Esquenazi1 concluded that LASIK was safe, effective, and stable for primary hyperopia between +1.00 and +3.00 D. In eyes with higher amounts of hyperopia, especially higher than +4.25 D, the long-term stability was poor. Esquenazi noted that chronic dry-eye symptoms (not uncommon in the treatment of higher hyperopia) were associated with regression over time. In a 5-year follow-up of LVC for hyperopia over a range of +0.75 to +7.00 D using the Summit Technology SVS Apex Plus excimer laser fitted with an Axicon, Jaycock et al.2 reported that LASIK was moderately effective in correcting low degrees of hyperopia. At 5 years, for treatments between +1.00 D and +3.00 D, 71.0% of eyes were within ±1.00 D of the intended correction; for treatments between +3.50 D and +6.00 D, only 37.5% of eyes were within ±1.00 D. However, the regression throughout the 5-year follow-up was greater than expected as a result of aging. Thus, the authors concluded that the long-term stability of hyperopic LASIK refractive correction was uncertain, with a hyperopic shift correlating with patient age and degree of hyperopia. Zadok et al.3 discussed the outcome of hyperopic LVC treatments using the Technolas 117C laser platform. At 12 months, the mean manifest spherical equivalent was within ±1.00 D of the intended correction in 93.1% of eyes in the low hyperopia group (<+3.00 D), 92.3% in the moderate hyperopia group (≥+3.00 to +6.00 D), but only 36.4% in the high hyperopia group (≥+6.00 to +10.00 D). The authors' modest conclusion was that “[l]aser in situ keratomileusis was a safe, effective, and predictable procedure for hyperopia up to +6.0 D and less predictable for higher hyperopia.” FACTORS IN THE MANAGEMENT OF HYPEROPIA Management of hyperopia must consider the following factors: diopters of hyperopia, age (accommodation, presbyopia), biometry (keratometry, corneal topography, aberrometry, anterior chamber depth, gonioscopy, endothelial status), and outcomes (permanence, quality of vision, remedies for complications). Diopters of Hyperopia Low hyperopia is generally suited to LVC subject to the age of the patient. Higher hyperopia, as shown above, is less predictable and a possible cause of the discontented patient. Higher hyperopia is best suited to RLE. Age The age of the patient is a major consideration of the applicability of a specific treatment. The older the patient, the higher the diopters of hyperopia, and the easier the decision in favor of RLE. Accommodation Lower degrees of hyperopia are managed successfully by the accommodative process in younger patients, although inevitably the need for correction will become manifest as presbyopia arrives, which may have a premature onset. Accommodation is always worth preserving until true accommodating replacement lenses are verified, as is the case for corneal presbyopic implants. Presbyopia Once accommodation is lost and a higher degree of hyperopia pertains, the case for RLE becomes incontrovertible. Biometry Awareness of ocular metrics is a vital part of the refractive surgery decision-making process. Keratometry Steep corneas are unsuitable for LVC depending on the degree of correction required. If the keratometry is greater than 48.0 D, tear-film problems (dry eye) may ensue and lead to unhappy patients, with the possible loss of quality of vision and the probability of regression of effect. Corneal Topography Understand before you treat is the dictum. Abnormal corneal shape may preclude LVC or may be a considered component of combined treatments. Aberrometry Aberrometry will provide an indication for LVC or indicate lenticular sources of aberration, thereby encouraging RLE. Anterior Chamber Depth The case for consideration of a pIOL solution for higher hyperopia is determined by the space between the corneal endothelium and the anterior capsule. If the space is greater than 3.0 mm, the options for pIOL implantation, either located in the posterior chamber or with an iris-clip IOL, are pertinent according to belief and experience.4,5 Gonioscopy Hyperopic eyes of short axial length and/or relatively flat corneas may be associated with narrow anterior chamber angles and the risk for angle closure. The solution to that problem coupled with the correction of hyperopia is RLE, a permanent correction of both problems. Endothelial Status In older patients, both pIOL and RLE solutions for the correction of hyperopia call for documentation and realization of the corneal endothelial status, as a baseline measurement before pIOL implantation in particular and for management of an intraocular procedure in general. Outcomes Permanence Laser vision correction is best described as a semipermanent solution because the crystalline lens remains the element that could change refraction and vision. The same argument applies to pIOL implantation, although it is additive and should not affect the refractive outcome of cataract refractive surgery. Lens surgery after LVC for hyperopia requires appropriate calculation of the pseudophakos dioptric power. Quality of Vision From their study, Ma et al.6 concluded that RLE was a better refractive procedure than LVC for minimizing the total higher-order optical aberrations that accompany hyperopic refractive surgery. They note that for a 3-diopter change in refraction in eyes with 6.0 mm pupils, LVC doubled the total higher-order root-mean-square (RMS) aberrations. Furthermore, LVC changed the sign of the spherical aberration from positive to negative by increasing the negative asphericity of the anterior cornea. However, the ablations in their 2004 study were performed with the Nidek EC-5000 platform with ablation zones of 5.5 to 6.0 mm and transition zones of 7.5 to 8.0 mm. In their 2007 analysis of higher-order wavefront aberrations after hyperopic laser-assisted subepithelial keratectomy, O'Brart et al.7 found no significant changes in RMS values postoperatively, except for a significant reduction in the 4th-order spherical aberration. Remedies for Complications Laser vision correction refractive complications may not have an LVC solution, while lens refractive complications may require an LVC correction. The process of refractive surgery may involve several treatment modalities.8,9,10 Laser vision correction surgery and lens surgery share the general risks of any surgical intervention, although the issue may be on the surface of the eye with LVC but intraocular with RLE or pIOL implantation. Complications are best avoided or reduced by selecting the appropriate refractive surgery intervention for each eye of each patient, bearing in mind the patient's age and degree of hyperopia.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Emanuel Rosen (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: